Document is current
Any future updates will be listed below
-
Authors
Gunes, Ilayda
Bernstein, Elana J.
Cowper, Shawn E.
Panse, Gauri
Pradhan, Niki
Camacho, Lucy Duran
Page, Nicolas
Bundschuh, Elizabeth
Williams, Alyssa
Carns, Mary
Aren, Kathleen
Fantus, Sarah
Volkmann, Elizabeth R.
Bukiri, Heather
Correia, Chase
Kolachalama, Vijaya B.
Wilson, F. Perry
Mawe, Seamus
Mahoney, J. Matthew
Hinchcliff, Monique
-
Funding
Funding for this research was provided by:
Kadmon Corporation LLC, a Sanofi company (GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287, GR112287)
Scleroderma Research Foundation (NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270, NIH NICHD K12 HD055884, NIAMS K23 AR059763, R21 AR068035, R01 AR073270)
National Heart, Lung, and Blood Institute (K23-AR-075112)
NATIONAL HEART, LUNG, & BLOOD INSTITUTE (R01-HL-164758, R01-HL159620)
Department of Defense grant (W81XWH-22-1-0163)
National Institute on Aging (R01-AG083735)
National Institute of General Medical Sciences (1R01GM141309, 1R01GM141309)
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 17 February 2025
First Online: 11 April 2025
Declarations
:
: The study protocol was approved by Kadmon Corporation LLC, a Sanofi company, and all participating site’s: Yale University, Columbia University, Northwestern University, and University of California, Los Angeles, Institutional Review Boards. Research partners provided written informed consent in accordance with the Declaration of Helsinki.
: Not applicable.
: MH has received consultancy fees from AbbVie and has received research grant support from Boehringer Ingelheim for an investigator-initiated research project. She is a Scientific Advisory Board Member for the Scleroderma Foundation. She has participated in clinical trials. EJB has received research grants from Kadmon, Boehringer Ingelheim and aTyr. EV has received consulting fees from Boehringer Ingelheim, GSK, Abbvie, BMS, and GLG, has received support from Boehringer Ingelheim, Horizon, Prometheus, Kadmon, and GSK, and serves on the advisory board for Cabaletta and Boehringer Ingelheim. FPW reports research support from AHRQ (R01HS027626), Amgen, and Whoop. FPW reports consulting for Hekaheart, Aura Care, and WndrHlth.
